Incidence of breakthrough fungal infections on isavuconazole prophylaxis compared to posaconazole and voriconazole.

Sara A Scott, Cory Perry,Zahra Mahmoudjafari,Grace A Martin,Samuel Boyd,Jeffrey Thompson, Beth Thomas

Transplant infectious disease : an official journal of the Transplantation Society（2023）

引用 5|浏览3

暂无评分

摘要

Patients who received isavuconazole prophylaxis during AML induction therapy or post-HCT experienced a similar incidence of breakthrough fungal infections compared to those who received posaconazole or voriconazole. These results suggest no difference in antifungal prophylactic efficacy; however larger prospective comparative studies are needed.

查看译文

关键词

AML,acute myeloid leukemia,alloHSCT,fungal prophylaxis,isavuconazole,posaconazole,stem cell transplant,voriconazole

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要